List of IGM Biosciences patents

List of IGM Biosciences patents

List of Shazam patents

List of General Atomics patents

List of Anterios patents

List of founders from Bridgeport, Connecticut

Films directed by Gregg Araki

Patents where

Current Assignee

Name

is

IGM Biosciences

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11535664 Multi-valent hepatitis B virus antigen binding molecules and uses thereof		IGM Biosciences	IGM Biosciences		United States Patent and Trademark Office	11535664	December 27, 2022
	‌ US Patent 11542342 Binding molecules with modified J-chain	Patent 11542342 was granted and assigned to IGM Biosciences on January, 2023 by the United States Patent and Trademark Office.	IGM Biosciences	IGM Biosciences		United States Patent and Trademark Office	11542342	January 3, 2023
	‌ US Patent 11401337 Modified human IgM constant regions for modulation of complement-dependent cytolysis effector function	Patent 11401337 was granted and assigned to IGM Biosciences on August, 2022 by the United States Patent and Trademark Office.	IGM Biosciences	IGM Biosciences		United States Patent and Trademark Office	11401337	August 2, 2022
	‌ US Patent 10351631 Constant chain modified bispecific, penta- and hexavalent Ig-M antibodies	Patent 10351631 was granted and assigned to IGM Biosciences on July, 2019 by the United States Patent and Trademark Office.	IGM Biosciences	IGM Biosciences		United States Patent and Trademark Office	10351631	July 16, 2019
	‌ US Patent 11578131 Polynucleotides encoding death domain-containing receptor-5 (DR5) binding molecules		IGM Biosciences	IGM Biosciences		United States Patent and Trademark Office	11578131	February 14, 2023
	‌ US Patent 11639389 Binding molecules with modified J-chain	Patent 11639389 was granted and assigned to IGM Biosciences on May, 2023 by the United States Patent and Trademark Office.	IGM Biosciences	IGM Biosciences		United States Patent and Trademark Office	11639389	May 2, 2023
	‌ US Patent 11555075 Modified J-chain	Patent 11555075 was granted and assigned to IGM Biosciences on January, 2023 by the United States Patent and Trademark Office.	IGM Biosciences	IGM Biosciences		United States Patent and Trademark Office	11555075	January 17, 2023
	‌ US Patent 10975147 Modified J-chain	Patent 10975147 was granted and assigned to IGM Biosciences on April, 2021 by the United States Patent and Trademark Office.	IGM Biosciences	IGM Biosciences		United States Patent and Trademark Office	10975147	April 13, 2021
	‌ US Patent 10400038 Modified J-chain	Patent 10400038 was granted and assigned to IGM Biosciences on September, 2019 by the United States Patent and Trademark Office.	IGM Biosciences	IGM Biosciences		United States Patent and Trademark Office	10400038	September 3, 2019
	‌ US Patent 10899835 IgM Fc and J-chain mutations that affect IgM serum half-life	Patent 10899835 was granted and assigned to IGM Biosciences on January, 2021 by the United States Patent and Trademark Office.	IGM Biosciences	IGM Biosciences		United States Patent and Trademark Office	10899835	January 26, 2021
	‌ US Patent 10954302 Anti-PD-L1 antibodies	Patent 10954302 was granted and assigned to IGM Biosciences on March, 2021 by the United States Patent and Trademark Office.	IGM Biosciences	IGM Biosciences		United States Patent and Trademark Office	10954302	March 23, 2021
	‌ US Patent 10689449 Multimeric death domain-containing receptor-5 (DR5) antibodies and uses thereof		IGM Biosciences	IGM Biosciences		United States Patent and Trademark Office	10689449	June 23, 2020
	‌ US Patent 10618978 Binding molecules with modified J-chain	Patent 10618978 was granted and assigned to IGM Biosciences on April, 2020 by the United States Patent and Trademark Office.	IGM Biosciences	IGM Biosciences		United States Patent and Trademark Office	10618978	April 14, 2020
	‌ US Patent 10787520 Multimeric bispecific binding molecules specific for CD20 and CD3		IGM Biosciences	IGM Biosciences		United States Patent and Trademark Office	10787520	September 29, 2020
	‌ US Patent 10604559 Multi-valent hepatitis B virus antigen binding molecules and uses thereof		IGM Biosciences	IGM Biosciences		United States Patent and Trademark Office	10604559	March 31, 2020
	‌ US Patent 10570191 Multi-valent human immunodeficiency virus antigen binding molecules and uses thereof	Patent 10570191 was granted and assigned to IGM Biosciences on February, 2020 by the United States Patent and Trademark Office.	IGM Biosciences	IGM Biosciences		United States Patent and Trademark Office	10570191	February 25, 2020
	‌ US Patent 10822399 IgA multi-specific binding molecules		IGM Biosciences	IGM Biosciences		United States Patent and Trademark Office	10822399	November 3, 2020
	‌ US Patent 11192941 Multi-valent human immunodeficiency virus antigen binding molecules and uses thereof	Patent 11192941 was granted and assigned to IGM Biosciences on December, 2021 by the United States Patent and Trademark Office.	IGM Biosciences	IGM Biosciences		United States Patent and Trademark Office	11192941	December 7, 2021

18 results

0 selected

18 results

0 selected